Company Description
Halozyme Therapeutics makes enzymes for therapeutic and drug delivery applications. The company's products are based on...
Key Halozyme Financials
| Company Type | Public - NASDAQ (GM): HALO Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $3.8 |
| 2006 Employees | 40 |
More Halozyme Financials (10 pages)
Latest Halozyme Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Halozyme's competition across multiple industries
Top Halozyme Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Halozyme Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Kenneth J. (Ken) Kelley | Network | E-mail |
| President, CEO, and Director | Jonathan E. Lim | Network | E-mail |
| VP and CFO | David A. Ramsay | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Halozyme News
- Halozyme Therapeutics Bladder Cancer Drug Chemophase Meets Study Goals [InvesTrend] (02 Jul 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (01 Jul 2008 23:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 22:00 ET [Briefing.com] (01 Jul 2008 22:01:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.